Sana Biotechnology Inc (NASDAQ: SANA) announced a portfolio prioritization expected to provide a cash runway into 2025. The resulting changes include focusing…
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.48) per share. This is a 29.73 percent decrease over losses of $(0.37) per share from the same period last year.
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.